David S. Margolis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
David S. Margolis has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Angela F. Smith
Department of Physical Therapy and Rehabilitation Science, University of Iowa, Iowa City, Iowa, USA
1 shared publication - Austen L. Thompson
From the Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN (Thompson, Khanna, and Yuan), Department of Orthopedic Surgery, Hennepin County Medical Center, Minneapolis, M.N. (Wagstrom), and Department of Orthopedic Surgery, Cedars-Sinai Medical Center, Los Angeles, CA (Little)
1 shared publication - Daniela Salvemini
Department of Pharmacology and Physiology, Saint Louis University School of Medicine, Saint Louis, MO, United States
1 shared publication - Deziree L. Coleman
Department of Medical Pharmacology, University of Arizona College of Medicine, Tucson, AZ, United States
1 shared publication - Dieter Mohty
Department of Medical Pharmacology, University of Arizona College of Medicine, Tucson, AZ, United States
1 shared publication - Erfan Bahramnejad
Department of Medical Pharmacology, University of Arizona College of Medicine, Tucson, AZ, United States
1 shared publication
Latest Publications
- Open Access
- 15 June 2023
- Published by Wolters Kluwer Health in Pain
- Vol. 164 (11) , 2463-2476
Morphine-induced osteolysis and hypersensitivity is mediated through toll-like receptor-4 in a murine model of metastatic breast cancer
The propensity for breast cancer to metastasize to bone is coupled to the most common complaint among breast cancer patients: bone pain. Classically, this type of pain is treated using escalating doses of opioids, which lack long-term efficacy due to analgesic tolerance, opioid-induced hypersensitivity, and have recently been linked to enhanced bone loss. To date, the molecular mechanisms underlying these adverse effects have not been fully explored. Using an immunocompetent murine model of metastatic breast cancer, we demonstrated that sustained morphine infusion induced a significant increase in osteolysis and hypersensitivity within the ipsilateral femur through the activation of toll-like receptor-4 (TLR4). Pharmacological blockade with TAK242 (resatorvid) as well as the use of a TLR4 genetic knockout ameliorated the chronic morphine-induced osteolysis and hypersensitivity. Genetic MOR knockout did not mitigate chronic morphine hypersensitivity or bone loss. In vitro studies using RAW264.7 murine macrophages precursor cells demonstrated morphine-enhanced osteoclastogenesis that was inhibited by the TLR4 antagonist. Together, these data indicate that morphine induces osteolysis and hypersensitivity that are mediated, in part, through a TLR4 receptor mechanism.
- 15 June 2023
- Published by Wolters Kluwer Health in Pain
- Vol. 164 (11) , 2463-2476
Open AccessMorphine-induced osteolysis and hypersensitivity is mediated through toll-like receptor-4 in a murine model of metastatic breast cancer
The propensity for breast cancer to metastasize to bone is coupled to the most common complaint among breast cancer patients: bone pain. Classically, this type of pain is treated using escalating doses of opioids, which lack long-term efficacy due to analgesic tolerance, opioid-induced hypersensitivity, and have recently been linked to enhanced bone loss. To date, the molecular mechanisms underlying these adverse effects have not been fully explored. Using an immunocompetent murine model of metastatic breast cancer, we demonstrated that sustained morphine infusion induced a significant increase in osteolysis and hypersensitivity within the ipsilateral femur through the activation of toll-like receptor-4 (TLR4). Pharmacological blockade with TAK242 (resatorvid) as well as the use of a TLR4 genetic knockout ameliorated the chronic morphine-induced osteolysis and hypersensitivity. Genetic MOR knockout did not mitigate chronic morphine hypersensitivity or bone loss. In vitro studies using RAW264.7 murine macrophages precursor cells demonstrated morphine-enhanced osteoclastogenesis that was inhibited by the TLR4 antagonist. Together, these data indicate that morphine induces osteolysis and hypersensitivity that are mediated, in part, through a TLR4 receptor mechanism.